BioCentury
ARTICLE | Politics, Policy & Law

FDA’s Pazdur supports expanded access for approved drugs

February 5, 2020 10:14 PM UTC
Updated on Feb 7, 2020 at 6:51 PM UTC

Richard Pazdur, director of FDA’s Oncology Center of Excellence, Wednesday said he supports authorizing expanded access requests for unapproved uses of approved medicines.

Although physicians can prescribe drugs for off-label indications, it can be difficult or impossible for patients to receive reimbursement. ...